Asia Pacific Genetic Testing Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
The Asia Pacific Genetic Testing Services Market size was valued at US$ 728.38 Mn in 2023 and is projected to reach US$ 2550.10 Mn by 2031, growing at a CAGR of 17.0% during 2023 - 2031.
Report Coverage
- Service Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Genetic Testing, Others
- Disease: Cancer, Cardiovascular Diseases, Metabolic Diseases, Other Diseases
- Service Provider: Hospital-Based Laboratories, Diagnostic Laboratories, Others
US$ 728.38 Mn
Market size in 2023
US$ 2550.10 Mn
Market Size by 2031
17.0%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Genetic Testing Services Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Genetic Testing Services Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Genetic Testing Services Market Regional Analysis
6.2 Asia Pacific Genetic Testing Services Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Genetic Testing Services Market Forecast Analysis
7. Asia Pacific Genetic Testing Services Market Analysis – by Service Type
7.1 Predictive Testing
- 7.1.1 Overview
- 7.1.2 Predictive Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Carrier Testing
- 7.2.1 Overview
- 7.2.2 Carrier Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Prenatal Testing
- 7.3.1 Overview
- 7.3.2 Prenatal Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Newborn Screening
- 7.4.1 Overview
- 7.4.2 Newborn Screening: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Diagnostic Genetic Testing
- 7.5.1 Overview
- 7.5.2 Diagnostic Genetic Testing: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Asia Pacific Genetic Testing Services Market Analysis – by Disease
8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Cardiovascular Diseases
- 8.2.1 Overview
- 8.2.2 Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Metabolic Diseases
- 8.3.1 Overview
- 8.3.2 Metabolic Diseases: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Other Diseases
- 8.4.1 Overview
- 8.4.2 Other Diseases: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Asia Pacific Genetic Testing Services Market Analysis – by Service Provider
9.1 Hospital-Based Laboratories
- 9.1.1 Overview
- 9.1.2 Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Asia Pacific Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Asia Pacific Genetic Testing Services Market – Asia Pacific Analysis
10.1 Overview
10.2 Asia Pacific- 10.2.1 Asia Pacific Genetic Testing Services Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 Asia Pacific Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Australia: Asia Pacific Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Australia: Asia Pacific Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.1.2 Australia: Asia Pacific Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.1.3 Australia: Asia Pacific Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.2 China: Asia Pacific Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 China: Asia Pacific Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.2.2 China: Asia Pacific Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.2.3 China: Asia Pacific Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.3 India: Asia Pacific Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 India: Asia Pacific Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.3.2 India: Asia Pacific Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.3.3 India: Asia Pacific Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.4 Japan: Asia Pacific Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Japan: Asia Pacific Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.4.2 Japan: Asia Pacific Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.4.3 Japan: Asia Pacific Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.5 South Korea: Asia Pacific Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 South Korea: Asia Pacific Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.5.2 South Korea: Asia Pacific Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.5.3 South Korea: Asia Pacific Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.6 Rest of Asia Pacific: Asia Pacific Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Rest of Asia Pacific: Asia Pacific Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.6.2 Rest of Asia Pacific: Asia Pacific Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.6.3 Rest of Asia Pacific: Asia Pacific Genetic Testing Services Market Breakdown, by Service Provider
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Eurofins Scientific SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Exact Sciences Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Laboratory Corp of America Holdings
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 23andMe Holding Co
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Ambry Genetics Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Quest Diagnostics Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Illumina Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 NeoGenomics Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Centogene NV
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Ancestry Genomics Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Gene By Gene Ltd
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 SIVOTEC BioInformatics LLC
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Progenesis
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Fulgent Genetics, Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 VERITAS INTERCONTINENTAL
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 GeneDx, LLC
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
